Industry Sector
Diagnostics — US PTAB Patent Cases
2 decisions indexed
Page 1 of 1 · 2 total
patent
Geneoscopy, Inc. v.Exact Sciences Corporation
· IPR2024-01330
Geneoscopy has filed an IPR petition seeking to invalidate claims 1‑4 and 12‑19 of Exact Sciences’ ’746 patent on the grounds of obviousness and lack of novelty, citing multiple prior‑art references.
patent
Fujirebio Diagnostics, Inc. v.Quanterix Corp.
· IPR2025-01060
Fujirebio Diagnostics petitions to invalidate Quanterix’s 2022 patent on tau‑protein blood assays, asserting that the method is obvious over existing single‑molecule array publications and an earlier tau‑diagnostic patent. The petition requests the PTAB to institute an IPR and cancel the challenged claims.
Arctic Invent — IP Strategy
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.